OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metabolic polygenic risk scores effect on antipsychotic-induced metabolic dysregulation: A longitudinal study in a first episode psychosis cohort
Àlex G. Segura, Albert Martínez-Pinteño, Patricia Gassó, et al.
Schizophrenia Research (2022) Vol. 244, pp. 101-110
Open Access | Times Cited: 15

Showing 15 citing articles:

Pharmacogenomic scores in psychiatry: systematic review of current evidence
Nigussie Tadesse Sharew, Scott Clark, Klaus Oliver Schubert, et al.
Translational Psychiatry (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 6

Genome-wide association study implicates lipid pathway dysfunction in antipsychotic-induced weight gain: multi-ancestry validation
Yundan Liao, Hao Yu, Yuyanan Zhang, et al.
Molecular Psychiatry (2024) Vol. 29, Iss. 6, pp. 1857-1868
Closed Access | Times Cited: 5

Polygenic risk scores enhance prediction of body mass index increase in individuals with a first episode of psychosis
Gerard Muntané, Javier Vázquez‐Bourgon, Ester Sada, et al.
European Psychiatry (2023) Vol. 66, Iss. 1
Open Access | Times Cited: 11

Bibliometric Analysis of Antipsychotic-induced Metabolic Disorder from 2006 to 2021 Based on WoSCC Database
Zhihao Guo, Zi Zhang, Lu Li, et al.
Current Neuropharmacology (2025) Vol. 23, Iss. 4, pp. 439-457
Closed Access

Applied pharmacogenetics to predict response to treatment of first psychotic episode: study protocol
Sergi Mas, Laura Julià, Manuel J. Cuesta, et al.
Frontiers in Psychiatry (2025) Vol. 15
Open Access

Deciphering the impact of metabolic anomalies in relation to severe mental illness
Clemente García-Rizo, Byron Kiiza Yafesi Bitanihirwe
European Neuropsychopharmacology (2024) Vol. 87, pp. 16-17
Closed Access | Times Cited: 3

The polygenic basis of relapse after a first episode of schizophrenia
Àlex G. Segura, L. Prohens, Patricia Gassó, et al.
European Neuropsychopharmacology (2023) Vol. 75, pp. 80-92
Open Access | Times Cited: 7

Polygenic risk scores analyses of psychiatric and metabolic traits with antipsychotic-induced weight gain in schizophrenia: an exploratory study
Kazunari Yoshida, Victoria S. Marshe, Samar S. M. Elsheikh, et al.
The Pharmacogenomics Journal (2023) Vol. 23, Iss. 5, pp. 119-126
Closed Access | Times Cited: 5

Nurse-led lifestyle intervention in a cohort of schizophrenia patients treated with clozapine
Andrea Mallorquí, Cristina Oliveira, José Ríos, et al.
Archives of Psychiatric Nursing (2023) Vol. 46, pp. 51-57
Open Access | Times Cited: 2

Association of clinical parameters and polygenic risk scores for body mass index, schizophrenia, and diabetes with antipsychotic-induced weight gain
M. Franz, Sergi Papiol, Maria S. Simon, et al.
Journal of Psychiatric Research (2023) Vol. 169, pp. 184-190
Closed Access | Times Cited: 2

Pharmacogenomic scores in psychiatry: Systematic review of existing evidence
Nigussie Tadesse Sharew, Scott Clark, Klaus Oliver Schubert, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

Bibliography

The MIT Press eBooks (2023), pp. 267-318
Open Access

Page 1

Scroll to top